SCHEMBL7328008

SCHEMBL7328008

Cc1noc(C)c1C(=O)Nc1ccc(-n2nccc2C)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.60
CRACR2A Q9BSW2 1/20 0.55
GAA P10253 4/20 0.55
TP53 P04637 1/20 0.55
ALDH1A1 P00352 6/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
ALOX15 P16050 2/20 0.50
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
RAB9A P51151 2/20 0.45
AGTR1 P30556 2/20 0.45
HRH3 Q9Y5N1 1/20 0.45
NPC1 O15118 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7321468 0.81 GFER (0.57) GFERCRACR2AGAATP53ALDH1A1
SCHEMBL10192173 0.80 GFER (0.74) GFERGAATP53ALDH1A1L3MBTL1
SCHEMBL7321056 0.78 CRACR2A (0.75) GFERCRACR2AGAATP53
SCHEMBL12637965 0.75 CRACR2A (0.77) GFERCRACR2AGAATP53HRH3
SCHEMBL7240068 0.75 CRACR2A (0.74) GFERCRACR2AGAATP53MAPT
SCHEMBL23657488 0.75 KMT2A (0.67) GFERGAATP53ALDH1A1L3MBTL1
SCHEMBL4422171 0.75 GAA (0.72) GFERGAATP53ALDH1A1L3MBTL1
SCHEMBL31610836 0.75 GAA (0.76) GFERGAATP53ALDH1A1L3MBTL1
SCHEMBL1668007 0.74 CRACR2A (0.76) GFERCRACR2AHRH3
SCHEMBL7321279 0.74 LMNA (0.58) ALDH1A1CYP1A2SMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP claimed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 GFER 2315/4885CRACR2A 3286/4885GAA 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.